Ze-lei Dai

Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study

N. Xu, T. Luo, Lei Liu, 2023, JMIR public health and surveillance.

Datopotamab deruxtecan versus docetaxel in previously treated advanced or metastatic non-small cell lung cancer: A cost-effectiveness analysis

Ningyue Xu, Ze-lei Dai, Zhongzheng Xiang, 2024, Lung Cancer.

Traditional Chinese medicine for gastric cancer: An evidence mapping

Nian Li, Ze-lei Dai, Lei Liu, 2024, Phytotherapy research : PTR.

The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancer

X. Zhong, Yuan-yuan Zeng, Z. Xiang, 2023, Frontiers in oncology.

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer

Lei Liu, T. Luo, X. Zhong, 2023, Cancer medicine.